CEFIXIME

Product NDC
70518-2749
Requested package NDC
70518-2749-3
11-digit product format
705182749
Labeler code
70518
Product ID
70518-2749_4a8d83f6-006d-5ac4-e063-6294a90abe49
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
CEFIXIME
Dosage form
CAPSULE
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA210574
Marketing category
ANDA
Marketing start
2020-05-21
Substance
CEFIXIME
Active strength
400 mg/1
Pharmacologic classes
Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage70518-274970518-2749-3DDiscontinued by firm2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source dateSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-312ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-100efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09557ba5c1ecfa…9c80585c8c6e…

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A210574-001CEFIXIMECEFIXIME400MGCAPSULE / ORALAB2018-10-09

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A210574-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07A210574-001CEFIXIME400MGCAPSULE / ORALAB2018-10-09caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A210574-001CEFIXIME400MGCAPSULE / ORALAB2018-10-09011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A210574-001CEFIXIME400MGCAPSULE / ORALAB2018-10-0931067a03dcf5…
2025-08-23 18:47 UTC2025-08A210574-001CEFIXIME400MGCAPSULE / ORALAB2018-10-096a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A210574-001CEFIXIME400MGCAPSULE / ORALAB2018-10-09fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A210574-001CEFIXIME400MGCAPSULE / ORALAB2018-10-09b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A210574-001CEFIXIME400MGCAPSULE / ORALAB2018-10-0903ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A210574-001CEFIXIME400MGCAPSULE / ORALAB2018-10-092680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A210574-001CEFIXIME400MGCAPSULE / ORALAB2018-10-095bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A210574-001CEFIXIME400MGCAPSULE / ORALAB2018-10-09d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A210574-001CEFIXIME400MGCAPSULE / ORALAB2018-10-09d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A210574-001CEFIXIME400MGCAPSULE / ORALAB2018-10-0979d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A210574-001CEFIXIME400MGCAPSULE / ORALAB2018-10-09301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A210574-001CEFIXIME400MGCAPSULE / ORALAB2018-10-091e350fbaab3a…
2024-05-31 18:47 UTC2024-05A210574-001CEFIXIME400MGCAPSULE / ORALAB2018-10-098072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A210574-001CEFIXIME400MGCAPSULE / ORALRS2018-10-095c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A210574-001CEFIXIME400MGCAPSULE / ORALRS2018-10-095d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A210574-001CEFIXIME400MGCAPSULE / ORALRS2018-10-094b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A210574-001CEFIXIME400MGCAPSULE / ORALAB2018-10-0974a2ff9319b5…
2022-03-09 01:35 UTC2022-03A210574-001CEFIXIME400MGCAPSULE / ORALRS2018-10-09bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A210574-001CEFIXIME400MGCAPSULE / ORALRS2018-10-09782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A210574-001CEFIXIME400MGCAPSULE / ORALRS2018-10-0987673890dc5c…
2021-03-12 10:30 UTC2021-03A210574-001CEFIXIME400MGCAPSULE / ORALRS2018-10-095aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A210574-001CEFIXIME400MGCAPSULE / ORALRS2018-10-098869cabd3fbd…
2020-11-12 02:37 UTC2020-11A210574-001CEFIXIME400MGCAPSULE / ORALRS2018-10-09c0c555d07b60…
2019-12-14 00:12 UTC2019-12A210574-001CEFIXIME400MGCAPSULE / ORALAB2018-10-093f01610625f2…
2019-09-15 20:21 UTC2019-09A210574-001CEFIXIME400MGCAPSULE / ORALAB2018-10-09b00525d2431f…
2019-07-19 19:46 UTC2019-07A210574-001CEFIXIME400MGCAPSULE / ORALAB2018-10-09ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A210574-001CEFIXIME400MGCAPSULE / ORALAB2018-10-096a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A210574-001CEFIXIME400MGCAPSULE / ORALAB2018-10-091c564ffb4f44…
2023-12-20 04:57 UTC2023-12A210574-001CEFIXIME400MGCAPSULE / ORALAB2018-10-09ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A210574-001CEFIXIME400MGCAPSULE / ORALAB2018-10-09a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A210574-001CEFIXIME400MGCAPSULE / ORALAB2018-10-099b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A210574-001CEFIXIME400MGCAPSULE / ORALAB2018-10-09a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A210574-001CEFIXIME400MGCAPSULE / ORALAB2018-10-093f0d92c62455…
2023-05-13 08:27 UTC2023-05A210574-001CEFIXIME400MGCAPSULE / ORALAB2018-10-09053a50430f4f…
2023-01-26 05:58 UTC2023-01A210574-001CEFIXIME400MGCAPSULE / ORALAB2018-10-093bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A210574-001CEFIXIME400MGCAPSULE / ORALAB2018-10-093a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A210574-001CEFIXIME400MGCAPSULE / ORALAB2018-10-09f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A210574-001CEFIXIME400MGCAPSULE / ORALAB2018-10-09e64feba35796…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-18 06:07:402026-07A210574-001AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A210574-001AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A210574-001AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A210574-001AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A210574-001AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A210574-001AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A210574-001AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A210574-001AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A210574-001AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A210574-001AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A210574-001AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A210574-001AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A210574-001AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A210574-001AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A210574-001AB18072bd15b7f6…
2019-12-13 00:20 UTC2019-12A210574-001AB174a2ff9319b5…
2019-12-14 00:12 UTC2019-12A210574-001AB13f01610625f2…
2019-09-15 20:21 UTC2019-09A210574-001AB1b00525d2431f…
2019-07-19 19:46 UTC2019-07A210574-001AB1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A210574-001AB16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A210574-001AB11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A210574-001AB1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A210574-001AB1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A210574-001AB19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A210574-001AB1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A210574-001AB13f0d92c62455…
2023-05-13 08:27 UTC2023-05A210574-001AB1053a50430f4f…
2023-01-26 05:58 UTC2023-01A210574-001AB13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A210574-001AB13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A210574-001AB1f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A210574-001AB1e64feba35796…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A210574-001AB1a50c72e98297…

Additional Listing Data#

Finished product
Yes
Brand name base
CEFIXIME
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
CEFIXIME400 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
97I1C92E55Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
409823Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
d6718f02-8eea-4c2f-9aa2-65121d9a6e4cAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
3b2162c7-9766-84dc-4509-6d61a89e78a5Product name520210729
7953affb-a49b-11df-6839-b5f62ce45d92Product name620210729

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDCEffectiveRelated label
70518-2749-02023-03-13These highlights do not include all the information needed to use CEFIXIME CAPSULES safely and effectively. See full prescribing information for CEFIXIME CAPSULES. CEFIXIME capsules, for oral use. Initial U.S. Approval: 1986
70518-2749-02023-03-13These highlights do not include all the information needed to use CEFIXIME CAPSULES safely and effectively. See full prescribing information for CEFIXIME CAPSULES. CEFIXIME capsules, for oral use. Initial U.S. Approval: 1986
70518-2749-12023-03-13These highlights do not include all the information needed to use CEFIXIME CAPSULES safely and effectively. See full prescribing information for CEFIXIME CAPSULES. CEFIXIME capsules, for oral use. Initial U.S. Approval: 1986
70518-2749-12023-03-13These highlights do not include all the information needed to use CEFIXIME CAPSULES safely and effectively. See full prescribing information for CEFIXIME CAPSULES. CEFIXIME capsules, for oral use. Initial U.S. Approval: 1986
70518-2749-22023-03-13These highlights do not include all the information needed to use CEFIXIME CAPSULES safely and effectively. See full prescribing information for CEFIXIME CAPSULES. CEFIXIME capsules, for oral use. Initial U.S. Approval: 1986
70518-2749-22023-03-13These highlights do not include all the information needed to use CEFIXIME CAPSULES safely and effectively. See full prescribing information for CEFIXIME CAPSULES. CEFIXIME capsules, for oral use. Initial U.S. Approval: 1986
70518-2749-32023-03-13These highlights do not include all the information needed to use CEFIXIME CAPSULES safely and effectively. See full prescribing information for CEFIXIME CAPSULES. CEFIXIME capsules, for oral use. Initial U.S. Approval: 1986
70518-2749-32023-03-13These highlights do not include all the information needed to use CEFIXIME CAPSULES safely and effectively. See full prescribing information for CEFIXIME CAPSULES. CEFIXIME capsules, for oral use. Initial U.S. Approval: 1986
70518-2749-02023-01-30These highlights do not include all the information needed to use CEFIXIME CAPSULES safely and effectively. See full prescribing information for CEFIXIME CAPSULES. CEFIXIME capsules, for oral use. Initial U.S. Approval: 1986
70518-2749-02023-01-30These highlights do not include all the information needed to use CEFIXIME CAPSULES safely and effectively. See full prescribing information for CEFIXIME CAPSULES. CEFIXIME capsules, for oral use. Initial U.S. Approval: 1986
70518-2749-12023-01-30These highlights do not include all the information needed to use CEFIXIME CAPSULES safely and effectively. See full prescribing information for CEFIXIME CAPSULES. CEFIXIME capsules, for oral use. Initial U.S. Approval: 1986
70518-2749-12023-01-30These highlights do not include all the information needed to use CEFIXIME CAPSULES safely and effectively. See full prescribing information for CEFIXIME CAPSULES. CEFIXIME capsules, for oral use. Initial U.S. Approval: 1986
70518-2749-22023-01-30These highlights do not include all the information needed to use CEFIXIME CAPSULES safely and effectively. See full prescribing information for CEFIXIME CAPSULES. CEFIXIME capsules, for oral use. Initial U.S. Approval: 1986
70518-2749-22023-01-30These highlights do not include all the information needed to use CEFIXIME CAPSULES safely and effectively. See full prescribing information for CEFIXIME CAPSULES. CEFIXIME capsules, for oral use. Initial U.S. Approval: 1986
70518-2749-32023-01-30These highlights do not include all the information needed to use CEFIXIME CAPSULES safely and effectively. See full prescribing information for CEFIXIME CAPSULES. CEFIXIME capsules, for oral use. Initial U.S. Approval: 1986
70518-2749-32023-01-30These highlights do not include all the information needed to use CEFIXIME CAPSULES safely and effectively. See full prescribing information for CEFIXIME CAPSULES. CEFIXIME capsules, for oral use. Initial U.S. Approval: 1986

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70518-2749-0CEFIXIME10 in 1 BOTTLE, PLASTICCAPSULE1013
70518-2749-1CEFIXIME1 in 1 BOTTLE, PLASTICCAPSULE113
70518-2749-2CEFIXIME2 in 1 BOTTLE, PLASTICCAPSULE213
70518-2749-3CEFIXIME2 in 1 BLISTER PACKCAPSULE213
70518-2749-4CEFIXIME1 in 1 POUCHCAPSULE113
70518-2749-5CEFIXIME2 in 1 BOXCAPSULE213

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
70518-2749-0EA - Each70518-27494a2a2e63-140b-49ca-97f8-6e6e6609a03f12024-04-05
70518-2749-2EA - Each70518-274912246bc9-96d6-4c1a-b009-828e4663cc0812026-01-08
70518-2749-4EA - Each70518-27491480d406-dd5f-4c3f-b2c2-d6d51763e98112026-01-08

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70518-2749CEFIXIME CAPSULE [REMEDYREPACK INC.]11Current NDC, Legacy NDC, 6 package rows20250125_d6718f02-8eea-4c2f-9aa2-65121d9a6e4c.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CEFIXIMECEFIXIMEREMEDYREPACK INC.d6718f02-8eea-4c2f-9aa2-65121d9a6e4c2026-07-28Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210574
application number: ANDA210574
ndc (package): 70518-2749-3
ndc (product): 70518-2749
ndc11 (package): 70518274903
Cefixime 400 mgCEFIXIMEHealth Department, Oklahoma Statef0fdb14b-e4fb-707e-e053-2a95a90a90492025-12-20WarningsExact identifier
application applno (ANDA): 210574
application number: ANDA210574
CEFIXIMECEFIXIMEAscend Laboratories, LLC6f1df975-f825-4301-87da-d7eba56a68902022-05-31Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210574
application number: ANDA210574

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
409823cefixime 400 MG Oral CapsulePSNd6718f02-8eea-4c2f-9aa2-65121d9a6e4c13
409823cefixime 400 MG Oral CapsuleSCDd6718f02-8eea-4c2f-9aa2-65121d9a6e4c13

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-2749-3705182749032 CAPSULE in 1 BLISTER PACK (70518-2749-3) 2 capsule2021-03-090000-00-00NoNoCurrent